Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-21-000778
Filing Date
2021-02-01
Accepted
2021-01-29 21:51:52
Documents
10

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2253962
2 GRAPHIC g39052g01a54.jpg GRAPHIC 67609
3 GRAPHIC g39052g02t68.jpg GRAPHIC 84067
4 GRAPHIC g39052g15k34.jpg GRAPHIC 69350
5 GRAPHIC g39052g26x34.jpg GRAPHIC 217627
6 GRAPHIC g39052g32y97.jpg GRAPHIC 115323
7 GRAPHIC g39052g49w92.jpg GRAPHIC 106598
8 GRAPHIC g39052g54z97.jpg GRAPHIC 36065
9 GRAPHIC g39052g73t03.jpg GRAPHIC 51153
10 GRAPHIC g39052g95w06.jpg GRAPHIC 132003
  Complete submission text file 0000950123-21-000778.txt   3428452
Mailing Address 180 VARICK STREET NEW YORK NY 10014
Business Address 180 VARICK STREET NEW YORK NY 10014 (617) 699-5876
ATAI Life Sciences B.V. (Filer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-04142 | Film No.: 21574057
SIC: 2834 Pharmaceutical Preparations